Liposome-mediated transfection of endothelial cells provides a valuable exp
erimental technique to study cellular gene expression and may also be adapt
ed for gene therapy studies. However, the widely recognized disadvantage of
liposome-mediated transfection is low efficiency. Therefore, studies were
performed to optimize transfection techniques in human endothelial cells. T
he majority of the experiments were performed with primary cultures of huma
n umbilical vein endothelial cells (HUVEC). In addition, selected experimen
ts were performed using human brain microvascular endothelial cells and hum
an dermal microvascular endothelial cells. To study transfection rates, HUV
EC were transfected with the pGL3 vector, containing the luciferase reporte
r gene, complexed with several currently available liposomes, such as diffe
rent Perfect Lipid (pFx) mixtures, DMRIE-C, or lipofectin. The optimal tran
sfection rate was achieved in HUVEC transfected for 1.5 h with 5 mug/ml of
DNA plasmid in the presence of 36 mug/ml of pFx-7, In addition, transfectio
n with the VR-3301 vector encoding for human placental alkaline phosphatase
revealed that, under the described conditions, transfection efficiency in
HUVEC was approximately 32%, Transfections mediated by other liposomes were
less efficient. The usefulness of the optimized transfection technique was
confirmed in HUVEC transfected with NF-kappaB or AP-1-responsive construct
s and stimulated with TNF or LPS. We conclude that among several currently
available liposomes, pFx-7 appears to be the most suitable for transfection
s of cultured human endothelial cells. Copyright (C) 2001 S. Karger AG, Bas
el.